Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Sudarshan

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Seminars in Oncology|October 19, 2006
Genetic basis of cancer of the kidneySunil Sudarshan, W Marston Linehan
Oncoscience|June 23, 2015
Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancerEun-Hee Shim, Sunil Sudarshan
Aging|March 29, 2016
Genetics of renal cancer: focus on MTORArindam P Ghosh, Sunil Sudarshan
European Urology|September 19, 2013
Do the sites of metastases provide additional information regarding prognosis and biology in renal cell carcinoma?Guru Sonpavde, Sunil Sudarshan, Bernard Escudier
Expert Opinion on Investigational Drugs|January 7, 2014
Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinomaGuru Sonpavde, Christopher D Willey, Sunil Sudarshan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Pseudohypoxic pathways in renal cell carcinomaGennady Bratslavsky, Sunil Sudarshan, Len Neckers, et al.
Seminars in Ultrasound, CT, and MR|August 29, 2009
Renal cell carcinoma: recent advances in genetics and imagingShaile Choudhary, Sunil Sudarshan, Peter L Choyke, et al.
Nature Clinical Practice. Urology|February 9, 2007
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancerSunil Sudarshan, Peter A Pinto, Len Neckers, et al.
Frontiers in Endocrinology|September 22, 2022
Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiationMary Taub, Nader H Mahmoudzadeh, Jason M Tennessen, et al.
Urology|November 16, 2005
Abnormal fluorescence in situ hybridization analysis in collecting duct carcinomaRyan Parker, H Mallory Reeves, Sunil Sudarshan, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Seminars in Oncology|October 19, 2006
Genetic basis of cancer of the kidneySunil Sudarshan, W Marston Linehan
Oncoscience|June 23, 2015
Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancerEun-Hee Shim, Sunil Sudarshan
Aging|March 29, 2016
Genetics of renal cancer: focus on MTORArindam P Ghosh, Sunil Sudarshan
European Urology|September 19, 2013
Do the sites of metastases provide additional information regarding prognosis and biology in renal cell carcinoma?Guru Sonpavde, Sunil Sudarshan, Bernard Escudier
Expert Opinion on Investigational Drugs|January 7, 2014
Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinomaGuru Sonpavde, Christopher D Willey, Sunil Sudarshan
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Pseudohypoxic pathways in renal cell carcinomaGennady Bratslavsky, Sunil Sudarshan, Len Neckers, et al.
Seminars in Ultrasound, CT, and MR|August 29, 2009
Renal cell carcinoma: recent advances in genetics and imagingShaile Choudhary, Sunil Sudarshan, Peter L Choyke, et al.
Nature Clinical Practice. Urology|February 9, 2007
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancerSunil Sudarshan, Peter A Pinto, Len Neckers, et al.
Frontiers in Endocrinology|September 22, 2022
Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiationMary Taub, Nader H Mahmoudzadeh, Jason M Tennessen, et al.
Urology|November 16, 2005
Abnormal fluorescence in situ hybridization analysis in collecting duct carcinomaRyan Parker, H Mallory Reeves, Sunil Sudarshan, et al.
Pageof 6